toxylact: a06ag11 laurilsulfate including combinations

The first professional lActological database in the word

Drugs in ATC class A06AG11 (lauryl sulfate, incl. combinations) are rectal emollient laxatives that act as surfactant stool softeners with negligible systemic exposure and are generally compatible with breastfeeding when used as indicated.medpedia.framar+3

Pharmacological group and composition

A06AG11 includes preparations containing sodium lauryl sulfate or sodium lauryl sulfoacetate, alone or in fixed combinations (e.g. with sodium citrate), classified as rectal enemas within the laxatives group for the treatment of constipation.atcddd.fhi+2
Lauryl sulfate is an anionic surfactant (organosulfate) with a C12 hydrophobic chain bound to a sulfate group, which confers amphiphilic detergent properties used in cleaning products, personal care items and as a pharmaceutical excipient.drugbank+2

Mechanism of action and indications

As emollient laxatives, A06AG11 products reduce stool surface tension, allowing water and lipids to penetrate the fecal mass, thereby softening stool and facilitating passage without strong stimulation of colonic motility.clevelandclinic+2
They are indicated for short‑term management of constipation, especially when avoidance of straining is desirable (e.g. anal fissures, postoperative states) and for bowel preparation when rectal softening is clinically useful.nhs+1

Systemic toxicity and local adverse effects

Rectal lauryl sulfate–based enemas are minimally absorbed; preparations in A06AG11 are therefore considered “not absorbed” or with practically nil systemic exposure under usual dosing, and systemic organ toxicity is not expected in standard use.e-lactation+2
The main toxicological concern is local irritation due to the surfactant effect (stinging, burning, itching, erythema) documented with topical medicinal products containing similar lauryl sulfate concentrations, particularly on compromised skin or mucosa.ema.europa+2
Accidental ingestion of large amounts of sodium lauryl sulfate can cause gastrointestinal distress, and high‑concentration or prolonged exposure may lead to skin or mucosal dermatitis, but such scenarios exceed the exposure profile of rectal laxatives in this ATC class.kidsadvisory+2

Use during lactation

Available data on lauryl sulfate in enemas show no quantifiable excretion in breast milk, and given the low dose and rectal route, clinically relevant transfer to the infant is not expected.sps+1
Specialist lactation sources classify sodium lauryl sulfate used rectally as compatible with breastfeeding, with low risk, and national guidance states that most laxatives (including stool softeners and enemas) can be used in breastfeeding because they are not absorbed or only minimally absorbed.e-lactation+1
Routine use according to recommended doses does not warrant interruption of breastfeeding; however, monitoring for maternal local intolerance (rectal burning, discomfort) is prudent, and unnecessary prolonged use beyond a few days should be avoided.sps+1

Clinical precautions

A06AG11 medicines should be reserved for symptomatic constipation and not used chronically; prolonged or excessive use may provoke diarrhoea, electrolyte disturbances or dependence on rectal laxatives similarly to other laxative classes.clevelandclinic+1
They should be administered with caution in patients with active proctitis, severe haemorrhoids or other rectal pathology, where surfactant‑induced irritation may worsen local symptoms, and all use should follow medical advice in pregnancy and lactation.medpedia.framar+2
If significant rectal pain, bleeding, or allergic manifestations occur after administration, treatment must be discontinued and medical assessment sought to exclude mucosal injury or hypersensitivity.ema.europa+1

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.